We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent’s Non-Small Cell Lung Cancer Companion Dx Receives Expanded FDA Approval

News   Oct 25, 2016

 
Agilent’s Non-Small Cell Lung Cancer Companion Dx Receives Expanded FDA Approval
 
 
 

RELATED ARTICLES

Testing Personalized Treatments in 5 days With 3D

News

Researchers have developed a cell co-culture platform that can reproduce a patient’s tumor in 3D and test the best treatment combinations for its specific case in just five days.

READ MORE

Molecular Escorts Keep Cancer in Check

News

A new study by Technical University of Munich (TUM) researchers uncovers the role of special proteins, known as chaperones, in the regulation of cellular machinery in cancer cells.

READ MORE

What Next After GWAS?

News

Genome-wide association studies (GWAS) look at large populations to find genes that contribute to common, multi-gene traits like height or obesity. These comprehensive studies frequently turn up large numbers of tiny genetic variations that occur more often in people who are tall, obese, etc. So which genes should scientists investigate further?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE